Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: kendall harmon who wrote (205)	8/31/1999 1:28:00 AM
From: Vector1	Read Replies (1) \| Respond to of 427

Thanks Kendall and PB. I am still shell shocked. Damm shorts have won this battle. Certainly not for the reason suggested by Avalon (ie manufacturing issues or hot v cold trial). My theory, and it is only that, is that the FDA staff which hates the 6 month review regulation turned this into a 9 month review by rejecting the application on ministerial changes that could have been handled a few weeks ago with a phone call. I know the company feels blindsided and I do not blame them. V1